BCL11A and Schnyder corneal dystrophy: The destruction of the erythrocyte-specific enhancer +58 BCL11A effectively reduced the expression of BCL11A and increased the HbF levels, as demonstrated in patients with beta-thalassemia and sickle cell disease (SCD) [17,51].